Molecular pharmacology of the calcitonin receptor

Brooke W Purdue, Nandasena Tilakaratne, Patrick Sexton

Research output: Contribution to journalArticleResearchpeer-review

82 Citations (Scopus)

Abstract

The peptide hormone calcitonin is widely used therapeutically in the treatment of bone disorders such as Paget s disease, osteoporosis, and the hypercalcemia of some malignancies. However, emerging evidence suggests the actions of calcitonin via its G protein-coupled receptor, the calcitonin receptor, may not be limited to bone. Calcitonin receptors have also been identified in the central nervous system, testes, skeletal muscle, lymphocytes, and the placenta. We are now becoming aware that the complexity of the calcitonin response mediated by the calcitonin receptor can be influenced by accessory proteins, receptor isoforms, genetic polymorphisms, developmental and/or transcriptional regulation, feedback inhibition, and the specific cellular or tissue background. This article discusses what is known about the molecular and pharmacological actions of the calcitonin receptor and highlights areas of current research.
Original languageEnglish
Pages (from-to)243 - 255
Number of pages13
JournalReceptors and Channels
Volume8
Issue number3 & 4
Publication statusPublished - 2002

Cite this

Purdue, B. W., Tilakaratne, N., & Sexton, P. (2002). Molecular pharmacology of the calcitonin receptor. Receptors and Channels, 8(3 & 4), 243 - 255.
Purdue, Brooke W ; Tilakaratne, Nandasena ; Sexton, Patrick. / Molecular pharmacology of the calcitonin receptor. In: Receptors and Channels. 2002 ; Vol. 8, No. 3 & 4. pp. 243 - 255.
@article{29218ab9188f4fdd96179cadb8aec964,
title = "Molecular pharmacology of the calcitonin receptor",
abstract = "The peptide hormone calcitonin is widely used therapeutically in the treatment of bone disorders such as Paget s disease, osteoporosis, and the hypercalcemia of some malignancies. However, emerging evidence suggests the actions of calcitonin via its G protein-coupled receptor, the calcitonin receptor, may not be limited to bone. Calcitonin receptors have also been identified in the central nervous system, testes, skeletal muscle, lymphocytes, and the placenta. We are now becoming aware that the complexity of the calcitonin response mediated by the calcitonin receptor can be influenced by accessory proteins, receptor isoforms, genetic polymorphisms, developmental and/or transcriptional regulation, feedback inhibition, and the specific cellular or tissue background. This article discusses what is known about the molecular and pharmacological actions of the calcitonin receptor and highlights areas of current research.",
author = "Purdue, {Brooke W} and Nandasena Tilakaratne and Patrick Sexton",
year = "2002",
language = "English",
volume = "8",
pages = "243 -- 255",
journal = "Receptors and Channels",
issn = "1060-6823",
number = "3 & 4",

}

Purdue, BW, Tilakaratne, N & Sexton, P 2002, 'Molecular pharmacology of the calcitonin receptor', Receptors and Channels, vol. 8, no. 3 & 4, pp. 243 - 255.

Molecular pharmacology of the calcitonin receptor. / Purdue, Brooke W; Tilakaratne, Nandasena; Sexton, Patrick.

In: Receptors and Channels, Vol. 8, No. 3 & 4, 2002, p. 243 - 255.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Molecular pharmacology of the calcitonin receptor

AU - Purdue, Brooke W

AU - Tilakaratne, Nandasena

AU - Sexton, Patrick

PY - 2002

Y1 - 2002

N2 - The peptide hormone calcitonin is widely used therapeutically in the treatment of bone disorders such as Paget s disease, osteoporosis, and the hypercalcemia of some malignancies. However, emerging evidence suggests the actions of calcitonin via its G protein-coupled receptor, the calcitonin receptor, may not be limited to bone. Calcitonin receptors have also been identified in the central nervous system, testes, skeletal muscle, lymphocytes, and the placenta. We are now becoming aware that the complexity of the calcitonin response mediated by the calcitonin receptor can be influenced by accessory proteins, receptor isoforms, genetic polymorphisms, developmental and/or transcriptional regulation, feedback inhibition, and the specific cellular or tissue background. This article discusses what is known about the molecular and pharmacological actions of the calcitonin receptor and highlights areas of current research.

AB - The peptide hormone calcitonin is widely used therapeutically in the treatment of bone disorders such as Paget s disease, osteoporosis, and the hypercalcemia of some malignancies. However, emerging evidence suggests the actions of calcitonin via its G protein-coupled receptor, the calcitonin receptor, may not be limited to bone. Calcitonin receptors have also been identified in the central nervous system, testes, skeletal muscle, lymphocytes, and the placenta. We are now becoming aware that the complexity of the calcitonin response mediated by the calcitonin receptor can be influenced by accessory proteins, receptor isoforms, genetic polymorphisms, developmental and/or transcriptional regulation, feedback inhibition, and the specific cellular or tissue background. This article discusses what is known about the molecular and pharmacological actions of the calcitonin receptor and highlights areas of current research.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12529940

M3 - Article

VL - 8

SP - 243

EP - 255

JO - Receptors and Channels

JF - Receptors and Channels

SN - 1060-6823

IS - 3 & 4

ER -

Purdue BW, Tilakaratne N, Sexton P. Molecular pharmacology of the calcitonin receptor. Receptors and Channels. 2002;8(3 & 4):243 - 255.